Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Predicted Market Size Trajectory For The Avian Flu Treatment Market From 2025 To 2034?
The avian flu treatment market size has seen significant expansion in recent years. It is anticipated to increase from $12.59 billion in 2024 to $13.77 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.3%. The market’s past growth is primarily due to an elevated demand for avian flu treatment, an uptick in efforts to prevent bird flu dissemination, the broader availability of treatment choices, greater investment in healthcare infrastructure, and an increased consumer demand for poultry.
The avian flu treatment market is projected to experience substantial expansion in the coming years, with its size forecast to reach $19.23 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.7%. This growth during the forecast period is primarily attributed to increasing awareness and diagnosis, government initiatives for pandemic preparedness, substantial research and development investments, and the critical need for effective therapeutics against avian influenza. Major trends anticipated in this period include the development of novel therapeutic approaches, future innovation and technologies, collaborative research efforts, new business development and investment opportunities, and the implementation of telemedicine and remote consultation.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16352&type=smp
What Are The Key Drivers Of Growth In The Avian Flu Treatment Market?
Increasing awareness and improved diagnosis are projected to propel the expansion of the avian flu treatment market in the future. Awareness refers to recognizing a health condition, whereas diagnosis involves pinpointing a particular problem stemming from that recognition. The necessity for avian flu treatment stems from the critical need to protect public health, avert potential pandemics, and shield poultry populations from substantial financial impacts. Effective avian flu treatment relies heavily on awareness and timely diagnosis, facilitating rapid intervention and containment measures to halt its spread. For example, data from April 2024, released by the World Health Organization (WHO), a Switzerland-based intergovernmental body, indicated that over 8000 individuals in the US were under active surveillance between February 9, 2022, and March 29, 2024, following exposure to animals suspected of being infected with the HPAI A (H5N1) virus. Consequently, the rise in awareness and diagnostic efforts is fueling growth within the avian flu treatment market.
What Are The Primary Types Of Segments Analyzed In The Avian Flu Treatment Market?
The avian flu treatmentmarket covered in this report is segmented –
1) By Type: Antibiotics; Vaccines; Antiviral Agents; Immunoglobulins
2) By Distribution Channel: Online Pharmacies; Offline Pharmacies
3) By End User: Hospital; Institutional Health Centers; Clinics
Subsegments:
1) By Antibiotics: Broad-Spectrum Antibiotics; Tetracycline Antibiotics; Penicillin-Based Antibiotics; Macrolide Antibiotics; Cephalosporins; Antimicrobial Peptides
2) By Vaccines: Inactivated Vaccines; Live Attenuated Vaccines; Recombinant Vaccines; Subunit Vaccines; Dna Vaccines; Bivalent And Multivalent Vaccines
3) By Antiviral Agents: Neuraminidase Inhibitors (Oseltamivir, Zanamivir); M2 Ion Channel Inhibitors (Amantadine); Polymerase Inhibitors; Protease Inhibitors; Antiviral Combination Therapies
4) By Immunoglobulins: Human Immunoglobulin (Ivig); Monoclonal Antibodies; Hyperimmune Serum; Polyvalent Immunoglobulins; Avian Flu-Specific Immunoglobulins
What Are The Latest Industry Trends Transforming The Avian Flu Treatment Market?
Leading companies within the avian flu treatment market are prioritizing the formation of partnerships to bolster effectiveness and hasten the creation of new therapies. Such collaborations involve joint efforts among pharmaceutical firms, research institutions, and government bodies to consolidate resources, exchange specialized knowledge, and carry out pioneering clinical trials. For example, in April 2024, CureVac N.V., a Germany-based biotechnology company, established a partnership with GSK plc, a UK-based pharmaceutical company, to develop an investigative influenza A (H5N1) pre-pandemic vaccine candidate aimed at addressing the potential future pandemic risk from the H5N1 avian influenza virus. This joint venture seeks to evaluate the safety, reactogenicity, and immunogenicity of the monovalent vaccine candidate, which utilizes CureVac’s proprietary second-generation mRNA backbone to encode an influenza A H5-antigen. The integrated Phase 1/2 study will evaluate the vaccine candidate’s safety and effectiveness in healthy adults aged 18 to 64, as well as in older adults aged 65 to 85.
Which Leading Players Are Enhancing Their Avian Flu Treatment Market Presence Worldwide?
Major companies operating in the avian flu treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Gilead Sciences Inc., Baxter International Inc., CSL Limited, Moderna Inc., Cipla Ltd., Shionogi & Co. Ltd., Novavax Inc., Seqirus Pty Ltd., Sinovac Biotech Ltd., Emergent BioSolutions Inc., Dynavax Technologies Corporation, CureVac AG, Valneva SE, BioCryst Pharmaceuticals Inc., Siga Technologies Inc., Aridis Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Biolyse Pharma
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/avian-flu-treatment-global-market-report
Which Region Currently Holds The Largest Share Of The Avian Flu Treatment Market?
North America was the largest region in the avian flu treatment market in 2024. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the avian flu treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Avian Flu Treatment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=16352&type=smp
Browse Through More Reports Similar to the Global Avian Flu Treatment Market 2025, By The Business Research Company
Sewage Treatment Facilities Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/sewage-treatment-facilities-global-market-report
Benign Prostatic Hyperplasia Bph Treatment Devices And Equipment Global Market Report 2025
Wastewater Treatment Equipment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model